PROTAC MDM2 Degrader-1 employs PROTAC technology to target and degrade MDM2. It consists of a potent MDM2 inhibitor linked to a ligand that interacts with E3 ubiquitin ligase, facilitating selective protein degradation. This structural design enhances the compound's ability to modulate protein levels effectively through targeted ubiquitination mechanisms.
Usually ships within 24 hours.